Preoperative portal vein embolization (PVE) for patients with hepatocellular carcinoma can improve resectability and may improve disease‐free survival

Preoperative portal vein embolization (PVE) for patients with hepatocellular carcinoma can improve resectability and may improve disease‐free survival
复制标题

DOI：
10.1002/jso.21928
复制
发表时间：
2011-11
期刊：
Journal of Surgical Oncology
影响因子：
2.5
通讯作者：
H. Okabe;T. Beppu;T. Ishiko;T. Masuda;H. Hayashi;Ryu Otao;Horlad Hasita;Kazutoshi Okabe;S. Sugiyama;H. Baba
H. Okabe;T. Beppu;T. Ishiko;T. Masuda;H. Hayashi;Ryu Otao;Horlad Hasita;Kazutoshi Okabe;S. Sugiyama;H. Baba
中科院分区：
医学3区
文献类型：
--
作者：
H. Okabe;T. Beppu;T. Ishiko;T. Masuda;H. Hayashi;Ryu Otao;Horlad Hasita;Kazutoshi Okabe;S. Sugiyama;H. Baba

文献摘要

被引文献

相似文献

本研究的目的是确定肝细胞癌 (HCC) 患者右肝切除术前门静脉栓塞 (PVE) 对肝功能、手术应激和生存获益的疗效。
The aim of this study is to identify the efficacy of portal vein embolization (PVE) before right hepatectomy in patients with hepatocellular carcinoma (HCC) with regard to hepatic function, surgical stress, and survival benefit.